These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 31060523)
1. Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes. da Costa AABA; do Canto LM; Larsen SJ; Ribeiro ARG; Stecca CE; Petersen AH; Aagaard MM; de Brot L; Baumbach J; Baiocchi G; Achatz MI; Rogatto SR BMC Cancer; 2019 May; 19(1):422. PubMed ID: 31060523 [TBL] [Abstract][Full Text] [Related]
2. Biomarker Assessment of HR Deficiency, Tumor Stronach EA; Paul J; Timms KM; Hughes E; Brown K; Neff C; Perry M; Gutin A; El-Bahrawy M; Steel JH; Liu X; Lewsley LA; Siddiqui N; Gabra H; Lanchbury JS; Brown R Mol Cancer Res; 2018 Jul; 16(7):1103-1111. PubMed ID: 29724815 [TBL] [Abstract][Full Text] [Related]
3. A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients. Tumiati M; Hietanen S; Hynninen J; Pietilä E; Färkkilä A; Kaipio K; Roering P; Huhtinen K; Alkodsi A; Li Y; Lehtonen R; Erkan EP; Tuominen MM; Lehti K; Hautaniemi SK; Vähärautio A; Grénman S; Carpén O; Kauppi L Clin Cancer Res; 2018 Sep; 24(18):4482-4493. PubMed ID: 29858219 [No Abstract] [Full Text] [Related]
4. Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations. Jean S; Li J; Katsaros D; Wubbenhorst B; Maxwell KN; Fishbein L; McLane MW; Benedetto C; Canuto EM; Mitra N; Zhang L; Nathanson KL; Tanyi JL Oncotarget; 2016 Jul; 7(30):48577-48585. PubMed ID: 27191893 [TBL] [Abstract][Full Text] [Related]
5. A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib. Liu JF; Xiong N; Wenham RM; Wahner-Hendrickson A; Armstrong DK; Chan N; O'Malley DM; Lee JM; Penson RT; Cristea MC; Abbruzzese JL; Matsuo K; Olawaiye AB; Barry WT; Cheng SC; Polak M; Swisher EM; Shapiro GI; Kohn EC; Ivy SP; Matulonis UA Gynecol Oncol; 2024 Aug; 187():105-112. PubMed ID: 38759516 [TBL] [Abstract][Full Text] [Related]
6. Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination. Fan L; Fei X; Zhu Y; Chi C; Pan J; Sha J; Xin Z; Gong Y; Du X; Wang Y; Dong B; Xue W J Urol; 2021 Sep; 206(3):630-637. PubMed ID: 33904759 [TBL] [Abstract][Full Text] [Related]
7. CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis. Ayhan A; Kuhn E; Wu RC; Ogawa H; Bahadirli-Talbott A; Mao TL; Sugimura H; Shih IM; Wang TL Mod Pathol; 2017 Feb; 30(2):297-303. PubMed ID: 27767100 [TBL] [Abstract][Full Text] [Related]
8. Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer. Nakayama N; Nakayama K; Shamima Y; Ishikawa M; Katagiri A; Iida K; Miyazaki K Cancer; 2010 Jun; 116(11):2621-34. PubMed ID: 20336784 [TBL] [Abstract][Full Text] [Related]
10. Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma. Liu Y; Yasukawa M; Chen K; Hu L; Broaddus RR; Ding L; Mardis ER; Spellman P; Levine DA; Mills GB; Shmulevich I; Sood AK; Zhang W JAMA Oncol; 2015 Jul; 1(4):486-94. PubMed ID: 26181259 [TBL] [Abstract][Full Text] [Related]
11. Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma. Feng Z; Shao D; Cai Y; Bi R; Ju X; Chen D; Song C; Chen X; Li J; An N; Li Y; Zhou Q; Xiu Z; Zhu S; Wu X; Wen H J Ovarian Res; 2023 Mar; 16(1):53. PubMed ID: 36922847 [TBL] [Abstract][Full Text] [Related]
12. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Pennington KP; Walsh T; Harrell MI; Lee MK; Pennil CC; Rendi MH; Thornton A; Norquist BM; Casadei S; Nord AS; Agnew KJ; Pritchard CC; Scroggins S; Garcia RL; King MC; Swisher EM Clin Cancer Res; 2014 Feb; 20(3):764-75. PubMed ID: 24240112 [TBL] [Abstract][Full Text] [Related]
13. Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer. Telli ML; Timms KM; Reid J; Hennessy B; Mills GB; Jensen KC; Szallasi Z; Barry WT; Winer EP; Tung NM; Isakoff SJ; Ryan PD; Greene-Colozzi A; Gutin A; Sangale Z; Iliev D; Neff C; Abkevich V; Jones JT; Lanchbury JS; Hartman AR; Garber JE; Ford JM; Silver DP; Richardson AL Clin Cancer Res; 2016 Aug; 22(15):3764-73. PubMed ID: 26957554 [TBL] [Abstract][Full Text] [Related]
14. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes. Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740 [TBL] [Abstract][Full Text] [Related]
15. Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing. Zhao Q; Yang J; Li L; Cao D; Yu M; Shen K; J Gynecol Oncol; 2017 Jul; 28(4):e39. PubMed ID: 28541631 [TBL] [Abstract][Full Text] [Related]
16. Synthetic lethality between CCNE1 amplification and loss of BRCA1. Etemadmoghadam D; Weir BA; Au-Yeung G; Alsop K; Mitchell G; George J; ; Davis S; D'Andrea AD; Simpson K; Hahn WC; Bowtell DD Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19489-94. PubMed ID: 24218601 [TBL] [Abstract][Full Text] [Related]
18. Genomic scar signatures associated with homologous recombination deficiency predict adverse clinical outcomes in patients with ovarian clear cell carcinoma. Chao A; Lai CH; Wang TH; Jung SM; Lee YS; Chang WY; Yang LY; Ku FC; Huang HJ; Chao AS; Wang CJ; Chang TC; Wu RC J Mol Med (Berl); 2018 Jun; 96(6):527-536. PubMed ID: 29725737 [TBL] [Abstract][Full Text] [Related]
19. Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer. Wen H; Feng Z; Ma Y; Liu R; Ou Q; Guo Q; Shen Y; Wu X; Shao Y; Bao H; Wu X BMC Cancer; 2022 May; 22(1):550. PubMed ID: 35578198 [TBL] [Abstract][Full Text] [Related]
20. Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Etemadmoghadam D; deFazio A; Beroukhim R; Mermel C; George J; Getz G; Tothill R; Okamoto A; Raeder MB; Harnett P; Lade S; Akslen LA; Tinker AV; Locandro B; Alsop K; Chiew YE; Traficante N; Fereday S; Johnson D; Fox S; Sellers W; Urashima M; Salvesen HB; Meyerson M; Bowtell D; Clin Cancer Res; 2009 Feb; 15(4):1417-27. PubMed ID: 19193619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]